Skip to content Skip to site navigation Skip to local navigation
Department of Health and Aged Care Department of Health and Aged Care

Medical Services Advisory Committee

  • MSAC
  • About MSAC
    • About MSAC
    • MSAC Terms of Reference
    • MSAC Membership
    • MSAC Executive Terms of Reference
    • ESC Terms of Reference
    • ESC Membership
    • PASC Terms of Reference
    • PASC Membership
  • MSAC Meetings
    • PASC, ESC, MSAC Key Dates
    • Codependent Technologies
    • Meeting Agendas
  • MSAC Processes
    • How to Apply for Public Funding
    • MSAC Process Framework
    • Frequently Asked Questions
    • Fact Sheets
  • Forms Templates & Guidelines
    • MSAC Guidelines
    • Documents for Applicants and Assessment Groups
    • Additional Resources
  • Engaging with MSAC
    • Information for Applicants
    • MSAC Consultation Process
  • MSAC Applications
    • Application Page
  • Utilisation Monitoring Process
  • You are here:
  • Medical Services Advisory Committee /
  • MSAC Meetings /
  • Meeting Agendas /

ESC - Meeting 5 - 6 October 2017

Page last updated: 15 November 2017

Medical Services Advisory Committee - Applications Considered

  • 1146.3 (SBA) - Capsule Endoscopy for the Diagnosis of Suspected Small Bowel Crohn Disease (Resubmission)
  • 1356 (CA) - Melanoma surveillance photography - total body photography and digital dermoscopy
  • 1407 (SBA) - EGFR mutation testing to determine eligibility for access to PBS subsidised AZD9291 second line therapy in patients with locally advanced or metastatic NSCLC
  • 1435 (CA) - Processing and cryopreservation of male and female gonadal tissue and gametes prior to or after gonadotoxic treatment to preserve fertility for the Future (Part A)
  • 1440.1 (SBA) - PD-L1 testing for access to pembrolizumab in treatment naïve patients with locally advanced or metastatic non-small cell lung cancer
  • 1454 (SBA) - Diagnostic testing for ROS proto-oncogene1 (ROS1) rearrangements in patients with non-small lung cancer (NSCLC) to determine eligibility for crizotinib treatment
  • 1473 (SBA) - 50 gene signature assay for predicting breast cancer recurrence
  • 1483 (SBA) - Micro-bypass stenting for open-angle glaucoma (in trabecular meshwork)
  • 1496 (SBA) - Micro-bypass stenting for open-angle glaucoma (external to Schlemm's canal)
Listen
  • MSAC Meetings
  • PASC, ESC, MSAC Key Dates
  • Codependent Technologies
  • Meeting Agendas
  • MSAC Email Bulletin


  • Feedback
Provide feedback

Comments will be used to improve web content and will not be responded to.

Real person check

This form uses a CAPTCHA to ensure that it is submitted by a person, instead of a machine or automated software.


Privacy statement

Your feedback has been submitted

Thank you for taking the time to provide feedback. It will be used to make improvements to this website.

Medical Services Advisory Committee

Medical Services Advisory Committee

© Commonwealth of Australia
ABN: 83 605 426 759

MBS Information

  • MBS Online
  • Legislation that covers the MBS
  • About MBS Factsheets
  • MBS Review

HTA Information

  • What is HTA
  • Australian Government HTA processes

Useful Links

  • MBS Online
  • PBS
  • PBAC
  • PLAC
  • Health Technology Reference Group
  • Healthier Medicare
  • MBS Review
  • TGA
  • HTA Conflict of Interest Guide

About

  • Copyright
  • Linking to this site
  • Accessibility
  • Disclaimer
  • Privacy
  • What is RSS?
  • Contact Us